VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 105 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 12.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $9,000 | -59.1% | 10,000 | -42.9% | 0.00% | 0.0% |
| Q1 2022 | $22,000 | -35.3% | 17,500 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $34,000 | -29.2% | 17,500 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $48,000 | -30.4% | 17,500 | -20.5% | 0.00% | -40.0% |
| Q2 2021 | $69,000 | +46.8% | 22,000 | 0.0% | 0.01% | +25.0% |
| Q1 2021 | $47,000 | +62.1% | 22,000 | +46.7% | 0.00% | +33.3% |
| Q4 2020 | $29,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Performa Ltd (US), LLC | 4,900 | $9,163 | 0.01% |